Purchase Order 75N91024P00532
Award Date 8/1/24
Potential Completion Date 7/31/25
Potential Value $50K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a preventive maintenance agreement on a government-owned BD Biosciences Influx 24 parameter cell sorter. The contract has a ceiling value of $126,846.00 and a period of performance from September 28, 2020 to September 28, 2023. The contract is not designated as a set-aside. BD, a large for-profit manufacturer of...
- This is a $1,994,840.77 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance services on various government-owned BD flow cytometry equipment over the base period ending on July 1, 2026. BD is a global medical technology company that specializes in flow cytometry, cell imaging, and...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on a BD Biosciences LSRFortessa Special Order Research Product (SORP) analytical cytometer. The one-year base period contract, valued at $64,584.00, provides preventive maintenance, repairs, software updates, and technical support for this specialized flow cytometry instrument used by the NCI's...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on two BD LSR Fortessa SORP flow cytometers. The contract has a base period of performance from April 17, 2021 through April 16, 2022, with four 12-month option periods, for a total potential value of $80,838. The contract does not have a set-aside designation. BD is a large, for-profit...
- This is a $90,720.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for annual maintenance and support of two BD FACSAria flow cytometry cell sorters. The contract covers two semi-annual preventive maintenance inspections, unlimited on-site emergency repair services, software updates, and technical support. The contract term is 12 months from September 1, 2023 to August 31,...
- This is a $93,978.96 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on a BD FACSymphony A5 flow cytometer and associated instrumentation. The contract is for a base period ending on March 31, 2024, with no set-aside designation. The contract was awarded without competition under simplified acquisition procedures for commercial items, as the NCI...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute (NCI) to Becton, Dickinson and Company (BD) for preventive maintenance services on four government-owned BD Biosciences flow cytometry instruments. The contract is valued at $156,957.12 and has a period of performance from September 1, 2022 to August 31, 2023. There is no set-aside designation for this award. BD is the prime contractor and...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance and support services for a BD LSR Fortessa flow cytometry instrument and associated instrumentation. The contract has a base period from August 1, 2021 to July 31, 2024, with a ceiling value of $73,900.44. The contract was awarded competitively without a set-aside designation, indicating...
- This is a sole-source, firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Becton, Dickinson and Company (BD) for preventive maintenance services on a government-owned BD LSRFortessa Flow Cytometer. The contract has an initial one-year period of performance with four 12-month option periods, and a total ceiling value of $144,941.40. BD, the original equipment...